{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T20:47:29Z","timestamp":1780519649219,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"T2 Biosystems","award":["-"],"award-info":[{"award-number":["-"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>T2Bacteria assay uses T2 magnetic resonance (T2MR) technology for the rapid diagnosis of bacterial bloodstream infections (BSIs). This FDA cleared technology can detect 5 of the most prevalent pathogens causing bacteremia (<jats:italic>Escherichia coli<\/jats:italic>, <jats:italic>Staphylococcus aureus, Klebsiella pneumoniae<\/jats:italic>, <jats:italic>Pseudomonas aeruginosa<\/jats:italic>, and <jats:italic>Enterococcus faecium<\/jats:italic>). Because the significance of discordant results between the T2Bacteria assay and blood culture (BC) remains a challenge, in this case series we reviewed the medical records of patients who had a positive T2Bacteria test and a concurrent negative BC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Among 233 participants, we identified 20 patients with 21 (9%) discordant T2Bacteria-positive\/BC-negative (T2+\/BC-) results. We classified these results based on clinical cultures and clinical evidence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>When we analyzed these 21 discordant results in-depth, 11 (52.5%) fulfilled criteria for probable BSI, 4 (19%) for possible BSI, and 6 (28.5%) were presumptive false positives. Among the probable\/possible BSIs, discordant results were often associated with patients diagnosed with closed space and localized infections [pyelonephritis (<jats:italic>n<\/jats:italic>\u2009=\u20097), abscess (<jats:italic>n<\/jats:italic>\u2009=\u20094), pneumonia (<jats:italic>n<\/jats:italic>\u2009=\u20091), infected hematoma (n\u2009=\u20091), and osteomyelitis (n\u2009=\u20091)]. Also, within the preceding 2\u2009days of the T2+\/BC- blood sample, 80% (16\/20) of the patients had received at least one dose of an antimicrobial agent which was active against the T2Bacteria-detected pathogen.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In the majority of discrepant results, the T2Bacteria assay detected a plausible pathogen that was supported by clinical and\/or microbiologic data. Discrepancies appear to be associated with closed space and localized infections and the recent use of effective antibacterial agents. The clinical significance and potential implications of such discordant results should be further investigated.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-020-05049-9","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T12:02:57Z","timestamp":1588852977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["In-depth analysis of T2Bacteria positive results in patients with concurrent negative blood culture: a case series"],"prefix":"10.1186","volume":"20","author":[{"given":"Markos","family":"Kalligeros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis M.","family":"Zacharioudakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giannoula S.","family":"Tansarli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Tori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Shehadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Mylonakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,7]]},"reference":[{"issue":"6","key":"5049_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.arcmed.2005.02.005","volume":"36","author":"GM Bearman","year":"2005","unstructured":"Bearman GM, Wenzel RP. Bacteremias: a leading cause of death. Arch Med Res. 2005;36(6):646\u201359.","journal-title":"Arch Med Res"},{"issue":"6","key":"5049_CR2","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1017\/S0950268806007631","volume":"135","author":"KB Laupland","year":"2007","unstructured":"Laupland KB, Gregson DB, Flemons WW, Hawkins D, Ross T, Church DL. Burden of community-onset bloodstream infection: a population-based assessment. Epidemiol Infect. 2007;135(6):1037\u201342.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"5049_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13054-017-1696-z","volume":"21","author":"CC Lee","year":"2017","unstructured":"Lee CC, Lee CH, Hong MY, Tang HJ, Ko WC. Timing of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremia. Crit Care. 2017;21(1):119.","journal-title":"Crit Care"},{"issue":"suppl_4","key":"5049_CR4","doi-asserted-by":"publisher","first-page":"iv27","DOI":"10.1093\/jac\/dky046","volume":"73","author":"ME Patch","year":"2018","unstructured":"Patch ME, Weisz E, Cubillos A, Estrada SJ, Pfaller MA. Impact of rapid, culture-independent diagnosis of candidaemia and invasive candidiasis in a community health system. J Antimicrob Chemother. 2018;73(suppl_4):iv27\u201330.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"5049_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1586\/eri.13.12","volume":"11","author":"JN Pendleton","year":"2013","unstructured":"Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens. Expert Rev Anti-Infect Ther. 2013;11(3):297\u2013308.","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"Suppl 1","key":"5049_CR6","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1086\/655995","volume":"31","author":"LB Rice","year":"2010","unstructured":"Rice LB. Progress and challenges in implementing the research on ESKAPE pathogens. Infect Control Hosp Epidemiol. 2010;31(Suppl 1):S7\u201310.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"5049_CR7","doi-asserted-by":"publisher","first-page":"2475067","DOI":"10.1155\/2016\/2475067","volume":"2016","author":"S Santajit","year":"2016","unstructured":"Santajit S, Indrawattana N. Mechanisms of antimicrobial resistance in ESKAPE pathogens. Biomed Res Int. 2016;2016:2475067.","journal-title":"Biomed Res Int"},{"issue":"12","key":"5049_CR8","doi-asserted-by":"publisher","first-page":"845","DOI":"10.7326\/M18-2772","volume":"170","author":"MH Nguyen","year":"2019","unstructured":"Nguyen MH, Clancy CJ, Pasculle AW, Pappas PG, Alangaden G, Pankey GA, et al. Performance of the T2Bacteria panel for diagnosing bloodstream infections: a diagnostic accuracy study. Ann Intern Med. 2019;170(12):845\u201352.","journal-title":"Ann Intern Med"},{"issue":"5","key":"5049_CR9","doi-asserted-by":"publisher","first-page":"R202","DOI":"10.1186\/cc12896","volume":"17","author":"J Phua","year":"2013","unstructured":"Phua J, Ngerng W, See K, Tay C, Kiong T, Lim H, et al. Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit Care. 2013;17(5):R202.","journal-title":"Crit Care"},{"issue":"4","key":"5049_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cmi.2015.01.003","volume":"21","author":"O Opota","year":"2015","unstructured":"Opota O, Croxatto A, Prod'hom G, Greub G. Blood culture-based diagnosis of bacteraemia: state of the art. Clin Microbiol Infect. 2015;21(4):313\u201322.","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 4","key":"5049_CR11","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/S0924-8579(09)70558-8","volume":"34","author":"S Stefani","year":"2009","unstructured":"Stefani S. Diagnostic techniques in bloodstream infections: where are we going? Int J Antimicrob Agents. 2009;34(Suppl 4):S9\u201312.","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"5049_CR12","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.jclinepi.2009.02.005","volume":"62","author":"JB Reitsma","year":"2009","unstructured":"Reitsma JB, Rutjes AW, Khan KS, Coomarasamy A, Bossuyt PM. A review of solutions for diagnostic accuracy studies with an imperfect or missing reference standard. J Clin Epidemiol. 2009;62(8):797\u2013806.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"5049_CR13","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.cmi.2018.05.016","volume":"25","author":"CS Scheer","year":"2019","unstructured":"Scheer CS, Fuchs C, Grundling M, Vollmer M, Bast J, Bohnert JA, et al. Impact of antibiotic administration on blood culture positivity at the beginning of sepsis: a prospective clinical cohort study. Clin Microbiol Infect. 2019;25(3):326\u201331.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"5049_CR14","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1128\/CMR.10.3.444","volume":"10","author":"LG Reimer","year":"1997","unstructured":"Reimer LG, Wilson ML, Weinstein MP. Update on detection of bacteremia and fungemia. Clin Microbiol Rev. 1997;10(3):444\u201365.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"5049_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s100960050453","volume":"19","author":"J Mylotte","year":"2000","unstructured":"Mylotte J, Tayara A. Blood cultures: clinical aspects and controversies. Eur J Clin Microbiol Infect Dis. 2000;19(3):157\u201363.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11 Suppl","key":"5049_CR16","doi-asserted-by":"publisher","first-page":"S513","DOI":"10.1097\/01.CCM.0000143119.41916.5D","volume":"32","author":"JC Marshall","year":"2004","unstructured":"Marshall JC, Maier RV, Jimenez M, Dellinger EP. Source control in the management of severe sepsis and septic shock: an evidence-based review. Crit Care Med. 2004;32(11 Suppl):S513\u201326.","journal-title":"Crit Care Med"},{"issue":"2","key":"5049_CR17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.7326\/0003-4819-106-2-246","volume":"106","author":"MD ARONSON","year":"1987","unstructured":"ARONSON MD, BOR DH. Diagnostic decision: blood cultures. Ann Intern Med. 1987;106(2):246\u201353.","journal-title":"Ann Intern Med"},{"issue":"2","key":"5049_CR18","first-page":"263","volume":"142","author":"GJ Pazin","year":"1982","unstructured":"Pazin GJ, Saul S, Thompson ME. Blood culture positivity: suppression by outpatient antibiotic therapy in patients with bacterial endocarditis. Arch Intern Med. 1982;142(2):263\u20138.","journal-title":"Arch Intern Med"},{"issue":"182","key":"5049_CR19","doi-asserted-by":"publisher","first-page":"182ra54","DOI":"10.1126\/scitranslmed.3005377","volume":"5","author":"LA Neely","year":"2013","unstructured":"Neely LA, Audeh M, Phung NA, Min M, Suchocki A, Plourde D, et al. T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood. Sci Transl Med. 2013;5(182):182ra54.","journal-title":"Sci Transl Med"},{"issue":"11","key":"5049_CR20","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1093\/cid\/cix1095","volume":"66","author":"CJ Clancy","year":"2018","unstructured":"Clancy CJ, Pappas PG, Vazquez J, Judson MA, Kontoyiannis DP, Thompson GR 3rd, et al. Detecting infections rapidly and easily for Candidemia trial, part 2 (DIRECT2): a prospective, multicenter study of the T2Candida panel. Clin Infect Dis. 2018;66(11):1678\u201386.","journal-title":"Clin Infect Dis"},{"key":"5049_CR21","doi-asserted-by":"crossref","unstructured":"Shehadeh F, Zacharioudakis IM, Zervou FN, Mylonakis E. Cost-effectiveness of rapid diagnostic assays that perform directly on blood samples for the diagnosis of septic shock. Diagn Microbiol Infect Dis. 2019.","DOI":"10.1016\/j.diagmicrobio.2019.02.018"},{"key":"5049_CR22","doi-asserted-by":"crossref","unstructured":"Weinrib DA, Capraro GA. The uncertain clinical benefit of the T2Bacteria panel. Ann Intern Med. 2019.","DOI":"10.7326\/M19-0971"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05049-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05049-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05049-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T23:23:01Z","timestamp":1620343381000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05049-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,7]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5049"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05049-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,7]]},"assertion":[{"value":"23 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Rhode Island Hospital IRB and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Mylonakis has received grant support from T2 Biosystems, Sanofi, Cidara Therapeutics and Kaleido Biosciences. The rest of the authors have disclosed no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"326"}}